Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Cardiovascular Calcification Market Growth Potential: How Will Market Size Shift Through 2030?
The cardiovascular calcification market has experienced substantial growth in recent years. Its value is projected to expand from $1.9 billion in 2025 to $2.05 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.7%. This historical progression can be attributed to factors such as an increasing aging population, the rising prevalence of cardiovascular diseases, the expansion of diagnostic imaging infrastructure, greater utilization of CT and MRI systems, and heightened awareness regarding the risks associated with vascular calcification.
The cardiovascular calcification market is projected to experience substantial expansion over the coming years. By 2030, its size is anticipated to reach $2.78 billion, exhibiting a compound annual growth rate (CAGR) of 7.9%. This growth during the forecast period is propelled by factors such as the heightened demand for accurate cardiovascular diagnostics, the increasing uptake of AI-powered imaging analysis, the broadening of minimally invasive diagnostic techniques, rising investments in preventive cardiology, and a greater emphasis on early intervention approaches. Key trends expected during this period involve the wider adoption of advanced cardiovascular imaging modalities, the growing utilization of calcium scoring and risk assessment tools, increasing integration of artificial intelligence in diagnostic imaging, the expansion of catheter-based diagnostic innovations, and a sharpened focus on the prompt detection of diseases.
Get A Free Sample Report With In-Depth Market Insights:
Cardiovascular Calcification Market Growth Catalysts And Demand Drivers
The increasing occurrence of cardiovascular diseases is anticipated to fuel the expansion of the cardiovascular calcification market in the future. These conditions involve disorders affecting the heart and blood vessels, resulting in issues like heart disease, stroke, and elevated blood pressure. The surge in cardiovascular diseases stems from inactive lifestyles and unhealthy eating patterns, which raise the likelihood of conditions such as hypertension, obesity, and damage to arteries. Cardiovascular calcification plays a crucial role in managing cardiovascular diseases by acting as an indicator for atherosclerosis and the accumulation of plaque, thereby facilitating the early identification of damage to the heart and blood vessels, and informing preventive or treatment strategies. For example, data from August 2025, released by the National Institutes of Health, a US-based government agency, indicates that between 2025 and 2050, the prevalence of cardiovascular conditions is expected to increase by 90%, mortality by 73%, and DALYs by 55%, with the number of deaths climbing from 20.5 million to 35.6 million. Consequently, the growing incidence of cardiovascular diseases is propelling the expansion of the cardiovascular calcification market.
Cardiovascular Calcification Market Breakdown By Product Type And Application
The cardiovascular calcification market covered in this report is segmented –
1) By Product Type: Imaging Systems; Atherectomy Devices; Stents; Transcatheter Valves
2) By Diagnosis: Computed Tomography (CT) Calcium Scoring; Echocardiography; Intravascular Ultrasound; Biomarkers
3) By Application: Coronary Artery Disease; Aortic Valve Stenosis; Peripheral Artery Disease; Chronic Kidney Disease (CKD) Related Vascular Calcification
4) By End User: Hospitals; Ambulatory Surgical Centers; Cardiac Clinics; Dialysis And Nephrology Centers
Subsegments:
1) By Imaging Systems: Magnetic Resonance Imaging; Computed Tomography Imaging; Ultrasound Imaging; Nuclear Imaging
2) By Atherectomy Devices: Rotational Atherectomy Devices; Directional Atherectomy Devices; Orbital Atherectomy Devices; Laser Atherectomy Devices
3) By Stents: Drug Eluting Stents; Bare Metal Stents; Bioabsorbable Stents; Balloon Expandable Stents
4) By Transcatheter Valves: Transcatheter Aortic Valves; Transcatheter Mitral Valves; Transcatheter Pulmonary Valves; Transcatheter Tricuspid Valves
Cardiovascular Calcification Market Trends Shaping Long-Term Demand
Leading companies within the cardiovascular calcification market are concentrating on developing advanced solutions, such as targeted intravascular shockwave energy delivery technology, to enhance the treatment of severely calcified lesions by improving lesion navigation, vessel adaptability, and the overall success rate of procedures. This targeted intravascular shockwave energy delivery technology represents a catheter-based therapeutic approach that emits controlled acoustic pressure waves inside blood vessels to fragment calcified plaque while preserving the surrounding soft tissue and vessel integrity. For instance, in March 2025, Shockwave Medical Inc., a US-based medical device company, launched a new forward intravascular lithotripsy platform in the US to revolutionize the treatment of hard-to-cross calcified lesions. This platform employs forward sonic pressure waves to break apart calcium in difficult-to-cross calcified peripheral artery lesions without requiring balloon inflation. Its purpose is to enable safe catheter advancement and vessel modification in complex peripheral artery disease (PAD) cases like critical limb-threatening ischemia (CLTI), ultimately improving outcomes compared to traditional instruments. Key benefits include a 99% technical success rate, minimal complications (1.1% major events), reduced risks of perforation or embolization, and increased efficiency for treatments below the knee, as evidenced by FORWARD PAD trial data.
Cardiovascular Calcification Market Key Participants And Competitive Landscape
Major companies operating in the cardiovascular calcification market are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Fujifilm Holdings Corporation, Royal Philips Healthcare, GE HealthCare Technologies Inc., Boston Scientific Corporation, Shimadzu Corporation, HeartFlow Inc., Aidoc Ltd., Neusoft Medical Systems Co. Ltd., Medis Medical Imaging Systems B.V., Pie Medical Imaging B.V., Canon Medical Systems Corporation, Keya Medical Technology Co. Ltd., Coreline Soft Co. Ltd., FastWave Medical Inc., Cleerly Inc., United Imaging Healthcare Co. Ltd., Zebra Medical Vision Ltd., Circle Cardiovascular Imaging Inc
View The Full Cardiovascular Calcification Market Report:
Cardiovascular Calcification Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the cardiovascular calcification market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiovascular calcification market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
